Home Health “Deadly virus in one out of three cases”

“Deadly virus in one out of three cases”

by admin
“Deadly virus in one out of three cases”

A case of hemorrhagic fever of the Crimea-Congo (known as CCHF) in Europa. A middle-aged man was in fact hospitalized in Spain with symptoms of the virus which causes, among other things, bleeding of the eyes. He was initially treated in a hospital in the Spanish region of Castile e León, before being flown elsewhere. CCHF is a disease with a mortality rate of 30%. Death that occurs within two weeks of the onset of the disease, according to the World Health Organization (WHO).

Marburg, the virus kills two people in Ghana: 98 in quarantine as “suspected contact” cases

Crimean-Congo hemorrhagic fever

Among the known symptoms of fever that originates from ticks besides eye bleeding, stomach pain, headache and vomiting. A patient may also experience joint pain, jaundice, mood swings, and red eyes in the early stages. As the virus progresses, symptoms can worsen to include “large areas of severe bruising” and “severe nosebleeds”. At the moment, there are no specific drugs available to treat CCHF, nor a vaccine against it, so experts work hard to stop its spread.

Prevention

The European Center for Disease Prevention and Control (ECDC) stresses that “prevention, early diagnosis and nursing to patients are the only means of avoiding the spread of the virus”. The name comes from the virus first identified in Crimea in 1944, before it was first isolated in the Congo region over a decade later. The spread of the virus is very difficult and the Center for DisesaseCotnrol and Prevention (CDC) explained that ticks are a “reservoir and vector” for the disease. There Crimean-Congo Hemorrhagic Fever is a viral hemorrhagic fever caused by a virus transmitted by ticks belonging to the genus Hyalomma. It has been identified in about thirty countries around the world. In recent years there has been a slight increase in cases with the identification of fever in South Africa, Senegal, Kenya, Mauritania, the Balkan countries, Turkey, Russia, Georgia, Tajikistan, Iran, Afghanistan and Pakistan.

See also  Kintor Pharmaceuticals Announces Phase III Clinical Results of New Crown Oral Drugs, Shares Up 106.37%_Drug_Virus_Antibody

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy